Re-excision rates after breast conserving surgery following the 2014 SSO-ASTRO guidelines-Reference-Cited by-同舟云学术

Re-excision rates after breast conserving surgery following the 2014 SSO-ASTRO guidelines

Published:2017-12 Issue:6 Volume:214 Page:1104-1109
ISSN:0002-9610
Container-title:The American Journal of Surgery
language:en
Short-container-title:The American Journal of Surgery

Author:

Heelan Gladden Alicia A.,Sams Sharon,Gleisner Ana,Finlayson Christina,Kounalakis Nicole,Hosokawa Patrick,Brown Regina,Chong Tae,Mathes David,Murphy Colleen

Funder

Department of Surgery Surgical Outcomes and Applied Research program

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference28 articles.

1. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer;Fisher;N. Engl J Med,2002

2. Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early-stage invasive breast carcinoma;Lazovich;Cancer,1999

3. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European organization for research and treatment of cancer 10801 trial;Dongen;J Natl Cancer Inst,2000

4. Randomized trials of breast-conserving therapy versus mastectomy for primary breast cancer;Jatoi;Am J Clin Oncol,2005

5. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy;Poggi;Cancer,2003

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisiting surgical margins for invasive breast cancer patients treated with breast conservation therapy - Evidence for adopting a 1 mm negative width;European Journal of Surgical Oncology;2024-10

2. Implementation of Choosing Wisely® Recommendations for Lymph Node Surgery in Male Breast Cancer;Annals of Surgical Oncology;2024-07-20

3. Radiological, pathological and surgical outcomes after neoadjuvant endocrine treatment in patients with ER-positive/HER2-negative breast cancer with a clinical high risk and a low-risk 70-gene signature;The Breast;2024-06

4. Tumor deformation correction for an image guidance system in breast conserving surgery;Medical Imaging 2022: Image-Guided Procedures, Robotic Interventions, and Modeling;2022-04-04

5. Validated prediction model for positive resection margins in breast-conserving surgery based exclusively on preoperative data;BJS Open;2021-09-06